-
When this checklist applies
-
Step 1: Classify the device and lock the regulatory pathway
-
Step 2: Actually read the clinical evidence
-
Step 3: Verify the QMS certificate scope, not just the logo
-
Step 4: Compare documentation against the physical product
-
Step 5: Audit labeling, UDI, and IFU together
-
Step 6: Write the receiving inspection protocol before the first shipment
-
Step 7: Put the re-evaluation on the calendar
-
What I'd watch for if I were starting over
When this checklist applies
If you're the person who signs off on medical device purchases—orthopedic implant lots, imaging hardware, sleep lab consumables, whatever lands on the loading dock—this checklist is for you. I've been running some version of these seven checks for four years. I've refined them every time something slipped through. Here they are in the order I actually perform them, not the order that looks good on a slide deck.
Step 1: Classify the device and lock the regulatory pathway
Medical devices aren't one category. A Class II diagnostic ultrasound system, a Class III orthopedic implant, a nuclear medicine camera, and a sleep diagnostic device all sit under different FDA pathways and different EU MDR annexes. Before I ask a supplier anything else, I confirm which pathway applies and whether their documentation actually matches it.
Case in point: a colleague once assumed a portable imaging unit was "just equipment." It required 510(k) clearance and the supplier hadn't mentioned it. That's a red flag, not a paperwork quirk. According to the FDA's device classification database (accessdata.fda.gov), most diagnostic ultrasound systems fall under Class II and require 510(k) premarket notification, while many implants follow PMA or De Novo routes. If you're fuzzy on what is medical ultrasound versus a therapeutic device, the classification lookup is where you start—not with the vendor's brochure.
Step 2: Actually read the clinical evidence
This is where a lot of people nod along and skip the work. I don't. When a supplier says a device is "clinically supported," I want citations—study size, endpoints, patient population, follow-up period. For orthopedic implants, I cross-check against registry data like the UK's NJR or the US AJRR. When we benchmarked a candidate supplier against Zimmer Biomet's published data—this was for a zimmer biomet medical devices orthopedic implants comparison memo—the gap wasn't in headline claims but in follow-up windows. One had five-year data; the other had two and implied the rest.
Same discipline applies to zimmer biomet clinical studies or any competitor's. I ask for the actual paper. If the rep can't produce it within a day, that's a deal-breaker for me.
Step 3: Verify the QMS certificate scope, not just the logo
ISO 13485 certification is table stakes. But the certificate has a scope statement, and I've seen suppliers whose certified scope covered dental instruments but not the implant line we were buying from. In the EU, the notified body and the MDR 2017/745 classification matter too—a Class III implant and a Class I instrument don't go through the same scrutiny.
"We're ISO 13485 certified" is a sentence, not a guarantee. Read the scope.
Step 4: Compare documentation against the physical product
I assumed "same specifications" meant identical results across vendors. Didn't verify. Turned out each had slightly different interpretations of tolerance and "industry standard."
That one cost us. We received a batch of implant components where the stated spec was ±0.05 mm against ASTM F136 dimensional requirements—our internal ceiling—and the measured deviation sat at ±0.08 mm. The vendor claimed it was "within industry standard." It wasn't within ours. We rejected the batch, they redid it at their cost, and now every contract includes explicit measurement tolerances and the inspection method. Numbers without a method are just decoration.
Step 5: Audit labeling, UDI, and IFU together
Labeling errors are the quiet killers. The FDA's UDI rule (21 CFR Part 830) requires a unique device identifier on labels and packaging, and it has to match the GUDID entry. I've seen mismatches between the IFU revision on the box and the one in the database—which, in a recall scenario, is exactly the kind of gap that turns a minor issue into a serious one.
For sterile-packed items, I check the seal integrity report and the sterilization validation date together. They're separate documents but one story.
Step 6: Write the receiving inspection protocol before the first shipment
We didn't have a formal receiving inspection process for the first eighteen months. Cost us when a pallet of sterile-packed instruments arrived with compromised seals and we had no documented baseline to reject against. The vendor argued the damage happened in transit. We had no counter-evidence.
The third time something like that happened, I finally wrote a protocol: sampling plan, acceptance criteria, photo documentation at unboxing, and a named sign-off. Should have done it after the first time.
The bottom line: a checklist that lives in your head isn't a checklist. It's a habit, and habits drift.
Step 7: Put the re-evaluation on the calendar
Most companies audit a supplier once, approve them, and never look again. I schedule a 12-month re-evaluation with a shorter 6-month documentation spot-check. Suppliers change ownership, move production lines, and update IFUs. If you're not checking, you're assuming—and I've already shown where that gets you.
What I'd watch for if I were starting over
A few things I wish someone had told me earlier:
- Don't confuse "FDA cleared" with "FDA approved." They mean different things, and using the wrong one in a procurement memo is embarrassing at best.
- The most frustrating part of supplier management is repetition. You'd think written specs would prevent misunderstandings, but interpretation varies wildly. The fix isn't better writing—it's verification at receiving.
- "Industry standard" is not a specification. It's a conversation starter. Ask for the number and the method behind it.
- What was best practice in 2020 may not apply in 2025. Digital UDI databases and registry transparency have changed what's checkable. The fundamentals of verification haven't changed, but the tools have.
In my opinion, the suppliers worth keeping are the ones who don't flinch when you ask for the underlying data. The ones who do—well, that's your answer.